Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 27.03.2024
Rosenbauer International
Refinancing agreement with lenders and capital increase
Topic: Rosenbauer reached a multilateral refinancing agreement with its
major lenders and promissory note holders. Further, the Austrian vehicle
manufacturer announced to be planning a capital increase of at least 3.4m
shares to strengthen its balance sheet.
Successful refinancing: Durin [ … ]
Wed, 27.03.2024
S Immo
FY ’23 showing strong rental growth - Strategy update // chg.
S IMMO released FY ’23 figures, showing strong operational results as well
as a lower-than-expected devaluation of the real estate portfolio.
FY rental income came in at € 203m (eNuW: € 193m; eCons: € 191m), up 30%
yoy thanks to acquisitions to the tune o [ … ]
Tue, 26.03.2024
ParTec AG
First Berlin Equity Research on 26/03/2024 initiated coverage on ParTec AG
(ISIN: DE000A3E5A34/ Bloomberg: JY0 GR). Analyst Simon Scholes placed a BUY
rating on the stock, with a EUR 220.00 price target.
Abstract:
Partec has designed, patented and brought to market a new type of
supercomputer, which for a given initial financial outlay, perform [ … ]
Tue, 26.03.2024
UmweltBank AG
Transformation year 2023 in line with expectations; further investments in
digitalisation and customer growth expected; return to profitability after
another transformation year 2024; price target: € 9.60; rating: BUY
UmweltBank AG published its preliminary figures for the past financial year
2023 on 18 March 2024. As expected, the pa [ … ]
Tue, 26.03.2024
M1 Kliniken AG
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG
(ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 13,20 auf EUR 18,00.
Zusammenfassung:
Wir bekräftigen unsere Kaufempfehlung für die M1 Kliniken AG (M1) und
erhöhen unser Ku [ … ]
Mon, 25.03.2024
PSI AG
First Berlin Equity Research has published a research update on PSI SE
(ISIN: DE000A0Z1JH9). Analyst Simon Scholes reiterated his BUY rating and
maintained his EUR 30.00 price target.
Abstract:
PSI has published preliminary key figures for 2023. Sales climbed 8.9% to
€269.9m (2022: €247.9m) while EBIT fell to €5.6m (2022: €2 [ … ]
Mon, 25.03.2024
ELARIS AG
25/03/2024 - GBC management interview with Lars Stevenson, CEO of ELARIS AG
'We expect a strong financial year in 2024, as driven by the continued
strong growth in the e-mobility market.'
ELARIS AG (ELARIS) is a German company and a provider of fully electric
e-vehicles in the fast-growing e-mobility sector. As an automotive
manufac [ … ]
Mon, 25.03.2024
LION E-Mobility
On the road for accelerating growth; chg. est.
Topic: LION E-Mobility published its FY23 prelims and FY24 guidance. While
the latter came in below our estimates, it offers plenty of room for
upside. Valuation remains highly attractive.
FY23 revenues increased by 4% yoy to € 56.1m, whereas € 26.3m came from Q4
alone. FY EBITDA stood [ … ]
Fri, 22.03.2024
VOQUZ Labs AG
Huge potential from promising PwC partnership // chg.
On Wednesday, VOQUZ Labs announced a strategic partnership with PwC
Solutions Germany for the marketing of remQ, the company’s business
transaction monitoring and auditing software for SAP customers. In detail:
PwC will offer its client base in Germany the establishment of a
digitali [ … ]
Fri, 22.03.2024
INDUS Holding AG
Strong FCF supports further growth; chg.
Topic: INDUS reported solid FY23 figures especially in light of the
currently challenging macro environment. Results are in line with the
preliminary numbers and FY23 guidance. Further, INDUS had its capital
markets day yesterday in Frankfurt. Here are the key takeaways:
FY23 sales came in at € 1. [ … ]
